Lung Cancer
Conference Coverage
Type of insurance linked to length of survival after lung surgery
Having public or a combination of public and private insurance was associated with worse 10-year overall survival.
News
Thoracic cancer approvals differ at FDA, EMA
The EMA had fewer approvals and took longer to make decisions.
Conference Coverage
In metastatic NSCLC, better QoL outcomes tied to better outcomes
But the authors of new research also found potential evidence that industry sponsorship may lead to a spin on QoL outcomes.
News
SBRT: Alternative to surgery in early stage lung cancer?
“From a public health perspective, SBRT is a good therapeutic option in terms of survival, especially for elderly and inoperable patients.”
News
Low-dose olanzapine improves appetite in chemotherapy patients
About half of patients who took olanzapine consumed more than 75% of recommended daily calories.
News
Cancer risk elevated after stroke in younger people
“Cancer represents a small percentage of causes of stroke. That means you would have to screen a lot of people with a benefit that is still...
Commentary
When practice-changing results don’t change practice
But among many of my colleagues who favor adjuvant over neoadjuvant therapy, it isn’t necessarily the fine points of the data that present the...
News
Depression tied to inflammation and survival in lung cancer
A new study’s findings underscore the importance of assessing and treating depression in patients with cancer, particularly given the high rate of...
Opinion
Logistical hassles hinder lifesaving lung cancer screenings
Scheduling lung cancer scans can be very difficult because of unwieldy internal processes.
News
Myths about smoking, diet, alcohol, and cancer persist
A new study shows how thinking has changed over time and how difficult it is to alter preconceived notions.